Advertisement
Advertisement

RCEL

RCEL logo

Avita Medical, Inc. Common Stock

3.93
USD
Sponsored
0.00
-0.10%
Feb 06, 15:59 UTC -5
Closed
exchange

After-Market

3.89

-0.04
-0.92%

RCEL Earnings Reports

Positive Surprise Ratio

RCEL beat 7 of 15 last estimates.

47%

Next Report

In 4 Days
Date of Next Report
Feb 12, 2026
Estimate for Q4 25 (Revenue/ EPS)
$18.19M
/
-$0.37
Implied change from Q3 25 (Revenue/ EPS)
+6.64%
/
-19.57%
Implied change from Q4 24 (Revenue/ EPS)
-1.15%
/
-15.91%

Avita Medical, Inc. Common Stock earnings per share and revenue

On Nov 06, 2025, RCEL reported earnings of -0.46 USD per share (EPS) for Q3 25, missing the estimate of -0.28 USD, resulting in a -58.78% surprise. Revenue reached 17.06 million, compared to an expected 18.55 million, with a -8.00% difference. The market reacted with a +10.88% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analysts forecast an EPS of -0.37 USD, with revenue projected to reach 18.19 million USD, implying an decrease of -19.57% EPS, and increase of 6.64% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q3 2025, Avita Medical, Inc. Common Stock reported EPS of -$0.46, missing estimates by -58.78%, and revenue of $17.06M, -8% below expectations.
The stock price moved up 10.88%, changed from $3.40 before the earnings release to $3.77 the day after.
The next earning report is scheduled for Feb 12, 2026.
Based on 7 analysts, Avita Medical, Inc. Common Stock is expected to report EPS of -$0.37 and revenue of $18.19M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement